Hematopoietic Stem Cell TransplantationInfant, NewbornRetrospective StudiesMycosesRisk FactorsCryptosporidiosisIncidenceGastroenteritisPrevalenceTime FactorsTreatment OutcomeCross InfectionCytomegalovirus InfectionsFecesBacteremiaRespiratory Tract InfectionsDisease Models, AnimalPolymerase Chain ReactionTransplantation, HomologousProspective StudiesMolecular Sequence DataEscherichia coli InfectionsAnti-Bacterial AgentsPregnancyCohort StudiesAge DistributionSequence Analysis, DNALungFollow-Up StudiesPostoperative ComplicationsRisk AssessmentGraft vs Host DiseaseCase-Control StudiesBase SequencePrognosisGenotypeSensitivity and SpecificityTransplantation ConditioningMutationUnited StatesMice, Inbred C57BLHematologic NeoplasmsTransplantation, AutologousTissue DonorsGraft vs Leukemia EffectLeukemiaMyeloablative AgonistsChimerismHistocompatibilityHematologic DiseasesHistocompatibility TestingBusulfanTransplantation ChimeraWhole-Body IrradiationHepatic Veno-Occlusive DiseaseVidarabineRecurrenceAspergillosisCord Blood Stem Cell TransplantationGraft vs Tumor EffectAntilymphocyte SerumSurvival AnalysisSiblingsPeripheral Blood Stem Cell TransplantationDonor SelectionSevere Combined ImmunodeficiencyLeukemia, Myeloid, AcuteBone Marrow TransplantationImmunocompromised HostLymphoproliferative DisordersAcute DiseaseStem Cell TransplantationMyelodysplastic SyndromesEuropeLymphohistiocytosis, HemophagocyticBronchiolitis ObliteransTransplantationSurvival RateImmunosuppressive AgentsHLA AntigensOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft SurvivalDisease-Free SurvivalAnemia, AplasticRemission InductionCytomegalovirusCystitisEnzyme Replacement TherapyThermometryTransplantation ImmunologyLymphocyte DepletionT-LymphocytesStomatitisCombined Modality TherapyImmunosuppressionSurvivorsMediterranean RegionNeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL Positive